The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF Variants
Abstract
Tumor necrosis factor (TNF) is a key regulator of inflammatory responses and has been implicated in many pathological conditions. We used structure-based design to engineer variant TNF proteins that rapidly form heterotrimers with native TNF to give complexes that neither bind to nor stimulate signaling through TNF receptors. Thus, TNF is inactivated by sequestration. Dominant-negative TNFs represent a possible approach to anti-inflammatory biotherapeutics, and experiments in animal models show that the strategy can attenuate TNF-mediated pathology. Similar rational design could be used to engineer inhibitors of additional TNF superfamily cytokines as well as other multimeric ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Caspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Boldin, M. P., Goncharov, T. M., Goltseve, Y. V., & Wallach, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81265-9 · Cited by 2,292
TNF-R1 Signaling: A Beautiful Pathway
Chen, G., & Goeddel, D. V. (2002) · Science · doi:10.1126/science.1071924 · Cited by 1,927
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Development of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673
TNF receptor subtype signalling: Differences and cellular consequences
MacEwan, D. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00262-5 · Cited by 610
Ruuls, S. R., Hoek, R. M., Ngo, V. N., McNeil, T., Lucian, L. A., Janatpour, M. J., Körner, H., Scheerens, H., Hessel, E. M., Cyster, J. G., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00215-1 · Cited by 246
Cytokine production by synovial T cells in rheumatoid arthritis
Steiner, G. (1999) · Rheumatology · doi:10.1093/rheumatology/38.3.202 · Cited by 228
Hishinuma, I., Nagakawa, J., Hirota, K., Miyamoto, K., Tsukidate, K., Yamanaka, T., Katayama, K., & Yamatsu, I. (1990) · Hepatology · doi:10.1002/hep.1840120518 · Cited by 154
Sreekrishna, K. T., Nelles, L. P., Potenz, R., Cruze, J. A., Mazzaferro, P. K., Fish, W. W., Fuke, M., Holden, K. A., & Phelps, D. A. (1989) · Biochemistry · doi:10.1021/bi00435a074 · Cited by 153
Combining computational and experimental screening for rapid optimization of protein properties
Hayes, R. J., Bentzien, J., Ary, M., Hwang, M. Y., Jacinto, J. M., Vielmetter, J., Kundu, A., & Dahiyat, B. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212627499 · Cited by 126
Self-citationBeutler, B. (2001) · Immunity · doi:10.1016/s1074-7613(01)00176-5 · Cited by 100
Mutational analysis of structure—activity relationships in human tumor necrosis factor-alpha
Yamagishi, J., Kawashima, H., Matsuo, N., Ohue, M., Yamayoshi, M., Fukui, T., Kotani, H., Furuta, R., Nakano, K., & Yamada, M. (1990) · Protein Engineering Design and Selection · doi:10.1093/protein/3.8.713 · Cited by 80
Computational stabilization of human growth hormone
Filikov, A. V., Hayes, R. J., Luo, P., Stark, D. M., Chan, C. S. C., Kundu, A., & Dahiyat, B. I. (2002) · Protein Science · doi:10.1110/ps.3500102 · Cited by 77
Self-citationNew Concepts in the Treatment of Rheumatoid Arthritis
Goldbach‐Mansky, R. T., & Lipsky, P. E. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152342 · Cited by 64
HORIUCHI, T., Yoshida, T., Koshihara, Y., SAKAMOTO, H., Kanai, H., Yamamoto, S., & Ito, H. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.643 · Cited by 50
Selective species specificity of tumor necrosis factor for toxicity in the mouse.
Brouckaert, P., Libert, C., Everaerdt, B., & Fiers, W. C. (1992) · PubMed · Cited by 49
Heterotrimers Formed by Tumor Necrosis Factors of Different Species or Muteins
Ameloot, P., Declercq, W., Fiers, W., Vandenabeele, P., & Brouckaert, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104486200 · Cited by 27
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018) · Bone Research · doi:10.1038/s41413-018-0016-9 · Cited by 1,767
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Self-citationTNF biology, pathogenic mechanisms and emerging therapeutic strategies
Kalliolias, G. D., & Ivashkiv, L. B. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.169 · Cited by 1,387
McCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 847
Self-citationAdipocyte inflammation is essential for healthy adipose tissue expansion and remodeling
Wernstedt Asterholm, I., Tao, C., Morley, T. S., Wang, Q. A., Delgado-Lopez, F., Wang, Z. V., & Scherer, P. E. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.005 · Cited by 668
Metadata
- Authors
- Steed, P. M., Tansey, M. G., Zalevsky, J., Zhukovsky, E. A., Desjarlais, J. R., Szymkowski, D. E., Abbott, C., Carmichael, D., Chan, C., Cherry, L., Cheung, P., Chirino, A. J., Chung, H. H., Doberstein, S. K., Eivazi, A., Filikov, A. V., Gao, S. X., Hubert, R. S., Hwang, M., Hyun, L., Kashi, S., Kim, A., Kim, E., Kung, J., Martinez, S. P., Muchhal, U. S., Nguyen, D.-H. T., O'Brien, C., O'Keefe, D., Singer, K., Vafa, O., Vielmetter, J., Yoder, S. C., & Dahiyat, B. I.
- Venue
- Science
- Published
- 2003-09-26
- Volume
- 301
- Issue
- 5641
- Pages
- 1895-1898
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2100078626
- Cited by
- 256
- References
- 21
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.